Is Cellebrite Stock a Good Investment?
Cellebrite Investment Advice | CLBT |
- Examine Cellebrite's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Cellebrite's leadership team and their track record. Good management can help Cellebrite navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Application Software space and any emerging trends that could impact Cellebrite's business and its evolving consumer preferences.
- Compare Cellebrite's performance and market position to its competitors. Analyze how Cellebrite is positioned in terms of product offerings, innovation, and market share.
- Check if Cellebrite pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Cellebrite's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Cellebrite DI stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Cellebrite DI is a good investment.
Sell | Buy |
Sell
Market Performance | Good | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Cellebrite Stock
Researching Cellebrite's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 47.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.6. Cellebrite DI had not issued any dividends in recent years.
To determine if Cellebrite is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cellebrite's research are outlined below:
| The company reported the previous year's revenue of 325.11 M. Net Loss for the year was (81.1 M) with profit before overhead, payroll, taxes, and interest of 219.91 M. | |
| About 47.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: Cellebrite and Relativity Deliver Solutions to Transform the Mobile Data Collection Landscape |
Cellebrite Quarterly Liabilities And Stockholders Equity |
|
Cellebrite uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Cellebrite DI. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cellebrite's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 15th of February 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 15th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Cellebrite's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Cellebrite's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-11-17 | 2022-09-30 | 0.02 | 0.01 | -0.01 | 50 | ||
2022-05-12 | 2022-03-31 | 0.02 | 0.01 | -0.01 | 50 | ||
2022-02-16 | 2021-12-31 | 0.02 | 0.03 | 0.01 | 50 | ||
2021-08-06 | 2021-06-30 | 0.06 | 0.05 | -0.01 | 16 | ||
2024-05-23 | 2024-03-31 | 0.06 | 0.08 | 0.02 | 33 | ||
2023-05-10 | 2023-03-31 | 0.02 | 0.04 | 0.02 | 100 | ||
2023-08-08 | 2023-06-30 | 0.02 | 0.05 | 0.03 | 150 | ||
2023-02-15 | 2022-12-31 | 0.04 | 0.08 | 0.04 | 100 |
Know Cellebrite's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cellebrite is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cellebrite DI backward and forwards among themselves. Cellebrite's institutional investor refers to the entity that pools money to purchase Cellebrite's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Pembroke Management Ltd | 2024-09-30 | 1.9 M | Ashford Capital Management Inc | 2024-06-30 | 1.9 M | Blackrock Inc | 2024-06-30 | 1.9 M | Crescent Park Management, L.p. | 2024-09-30 | 1.7 M | Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Ltd | 2024-09-30 | 1.5 M | Renaissance Technologies Corp | 2024-09-30 | 1.5 M | Principal Financial Group Inc | 2024-09-30 | 1.4 M | Two Sigma Investments Llc | 2024-06-30 | 1.4 M | Goldman Sachs Group Inc | 2024-06-30 | 1.3 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 14 M | True Wind Capital Management, L.p. | 2024-09-30 | 11.7 M |
Cellebrite's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.08 B.Market Cap |
|
Cellebrite's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.16) | (0.15) | |
| Return On Capital Employed | 0.12 | 0.12 | |
| Return On Assets | (0.15) | (0.14) | |
| Return On Equity | (2.37) | (2.25) |
Determining Cellebrite's profitability involves analyzing its financial statements and using various financial metrics to determine if Cellebrite is a good buy. For example, gross profit margin measures Cellebrite's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cellebrite's profitability and make more informed investment decisions.
Cellebrite's Earnings Breakdown by Geography
Please note, the imprecision that can be found in Cellebrite's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cellebrite DI. Check Cellebrite's Beneish M Score to see the likelihood of Cellebrite's management manipulating its earnings.
Evaluate Cellebrite's management efficiency
Cellebrite DI has return on total asset (ROA) of 0.0635 % which means that it generated a profit of $0.0635 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.885) %, meaning that it created substantial loss on money invested by shareholders. Cellebrite's management efficiency ratios could be used to measure how well Cellebrite manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.12 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (0.15). Total Current Liabilities is likely to drop to about 199.5 M in 2024. Liabilities And Stockholders Equity is likely to drop to about 424.2 M in 2024| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.18 | 0.20 | |
| Tangible Book Value Per Share | (0.02) | (0.02) | |
| Enterprise Value Over EBITDA | (22.71) | (21.57) | |
| Price Book Value Ratio | 48.13 | 50.54 | |
| Enterprise Value Multiple | (22.71) | (21.57) | |
| Price Fair Value | 48.13 | 50.54 | |
| Enterprise Value | 1.7 B | 1.5 B |
Cellebrite's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Beta 1.499 |
Basic technical analysis of Cellebrite Stock
As of the 22nd of November, Cellebrite shows the Downside Deviation of 1.57, mean deviation of 1.43, and Risk Adjusted Performance of 0.0866. Cellebrite DI technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Cellebrite's Outstanding Corporate Bonds
Cellebrite issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cellebrite DI uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cellebrite bonds can be classified according to their maturity, which is the date when Cellebrite DI has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Understand Cellebrite's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Cellebrite's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0866 | |||
| Market Risk Adjusted Performance | 0.3796 | |||
| Mean Deviation | 1.43 | |||
| Semi Deviation | 1.32 | |||
| Downside Deviation | 1.57 | |||
| Coefficient Of Variation | 935.34 | |||
| Standard Deviation | 1.93 | |||
| Variance | 3.73 | |||
| Information Ratio | 0.0575 | |||
| Jensen Alpha | 0.1512 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0708 | |||
| Treynor Ratio | 0.3696 | |||
| Maximum Drawdown | 8.74 | |||
| Value At Risk | (2.24) | |||
| Potential Upside | 3.55 | |||
| Downside Variance | 2.47 | |||
| Semi Variance | 1.75 | |||
| Expected Short fall | (1.72) | |||
| Skewness | 0.9078 | |||
| Kurtosis | 2.11 |
| Risk Adjusted Performance | 0.0866 | |||
| Market Risk Adjusted Performance | 0.3796 | |||
| Mean Deviation | 1.43 | |||
| Semi Deviation | 1.32 | |||
| Downside Deviation | 1.57 | |||
| Coefficient Of Variation | 935.34 | |||
| Standard Deviation | 1.93 | |||
| Variance | 3.73 | |||
| Information Ratio | 0.0575 | |||
| Jensen Alpha | 0.1512 | |||
| Total Risk Alpha | (0.02) | |||
| Sortino Ratio | 0.0708 | |||
| Treynor Ratio | 0.3696 | |||
| Maximum Drawdown | 8.74 | |||
| Value At Risk | (2.24) | |||
| Potential Upside | 3.55 | |||
| Downside Variance | 2.47 | |||
| Semi Variance | 1.75 | |||
| Expected Short fall | (1.72) | |||
| Skewness | 0.9078 | |||
| Kurtosis | 2.11 |
Consider Cellebrite's intraday indicators
Cellebrite intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cellebrite stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Cellebrite Corporate Filings
6K | 6th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
F3 | 17th of September 2024 An amendment to the original Schedule 13D filing | ViewVerify |
| 12th of April 2024 Other Reports | ViewVerify | |
| 21st of March 2024 Other Reports | ViewVerify |
Cellebrite Stock media impact
Far too much social signal, news, headlines, and media speculation about Cellebrite that are available to investors today. That information is available publicly through Cellebrite media outlets and privately through word of mouth or via Cellebrite internal channels. However, regardless of the origin, that massive amount of Cellebrite data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cellebrite news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cellebrite relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cellebrite's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cellebrite alpha.
Cellebrite Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Cellebrite can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Cellebrite DI Historical Investor Sentiment
Investor biases related to Cellebrite's public news can be used to forecast risks associated with an investment in Cellebrite. The trend in average sentiment can be used to explain how an investor holding Cellebrite can time the market purely based on public headlines and social activities around Cellebrite DI. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Cellebrite's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cellebrite and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Cellebrite news discussions. The higher the estimate score, the more favorable the investor's outlook on Cellebrite.
Cellebrite Corporate Management
| Yossi Carmil | CEO Founder | Profile | |
| Zohar TadmorEilat | Chief Officer | Profile | |
| Osnat Tirosh | Chief Officer | Profile | |
| David Gee | Chief Officer | Profile | |
| Adam Jaffe | VP Communications | Profile | |
| Ayala Shapira | General Counsel | Profile |
Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.